Curtis Reinke, MD
Internal Medicine · Olympia, WANPI 1609958271
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 424 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 48 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 424 payments — averaging $32.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$1K
- Lilly USA, LLC$1K
- Boehringer Ingelheim$1K
- Amgen$791
- Johnson & Johnson$778
- plus $6K from 42 others
What the payments were for
- Food & beverage$13,64899%
- Education$1371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$601
- BREZTRI$554
- VRAYLAR$375
- FARXIGA$350
- Kerecis Omega3 Marigen$345
- XARELTO$326
- Ozempic$234
- JARDIANCE$230
- Kerendia$225
- DALVANCE$128
- Otezla$125
- Fanapt$125
- CAPLYTA$125
- Repatha$120
- Kerecis Omega3 SurgiClose$115
- Kerecis Omega3 GraftGuide$115
- AIMOVIG$112
- AREXVY$110
- ENTRESTO$109
How this compares
$13,785 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 47 | $63,134 |
| FarxigaDapagliflozin Propanediol | 61 | $56,649 |
| JardianceEmpagliflozin | 39 | $52,037 |
| EliquisApixaban | 40 | $45,605 |
| MounjaroTirzepatide | 26 | $28,087 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 49 | $22,998 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $21,721 |
| XareltoRivaroxaban | 21 | $20,235 |
| Repatha SureclickEvolocumab | 18 | $17,713 |
| TradjentaLinagliptin | 11 | $12,068 |
| LantusInsulin Glargine,hum.Rec.Anlog | 29 | $10,958 |
| OxycontinOxycodone Hcl | 12 | $9,978 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $9,823 |
| Novolog FlexpenInsulin Aspart | 38 | $9,535 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $7,531 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $2,118 | $78,37079 claims |
| Boehringer IngelheimJardiance, Tradjenta | $1,095 | $64,10550 claims |
| Novo NordiskOzempic | $650 | $63,13447 claims |
| PfizerEliquis | $450 | $45,60540 claims |
| Lilly USA, LLCMounjaro | $1,152 | $28,08726 claims |
| Johnson & JohnsonXarelto | $778 | $20,23521 claims |
| Sanofi-aventis U.S. LLCLantus | $730 | $10,95829 claims |
| AbbVieSynthroid, Viibryd | $1,431 | $10,74682 claims |
| GSKAnoro Ellipta | $228 | $7,53114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,038 internal medicine providers in Washington.
Other internal medicine in Olympia
- Shawna PurcellOlympia$294K
- Eric KleinOlympia$23K
- Sabrina BenjaminOlympia$7K
- Rebecca MarchOlympia$7K
- Peter ShalitSeattle$1M
- Lawrence LoebBellevue$784K
- Scott RamseySeattle$230K
- Michael CairnsSeattle$144K
- Peiqing QianSeattle$117K
- Alan KellySpokane Valley$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.